Results 141 to 143 of about 766 (143)

Production of certified reference materials for the sports doping control of the REV‐ERB agonist SR9009

Drug Testing and Analysis, 2019
Stephen Davies
exaly  

Attività sinergica di sorafenib e SR9009 contro cellule di epatocarcinoma umano e murino: studi in vitro ed in vivo

Hepatocellular carcinoma (HCC) is the sixth most common malignancy and the third leading cause of cancer death worldwide. The prognosis for advanced HCC is poor. Despite recent therapeutic advances, life expectancy remains limited due to the aggressive nature of the disease, often late diagnosis, and insufficient efficacy of available therapies.
openaire   +1 more source

Rapid Investigating of the Sr9009 Metabolites Via Feature-Based Molecular Networking Approach: Potential Applications in Doping Control

Young Beom Kwak, Jungho Yoon, Hye Hyun Yoo   +2 more
openaire   +1 more source